Insights into deregulated TNF and IL-10 production in malaria: implications for understanding severe malarial anaemia

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Insights into deregulated TNF and IL-10 production in malaria : implications for understanding severe malarial anaemia. / Boeuf, Philippe S; Loizon, Séverine; Awandare, Gordon A; Tetteh, John Ka; Addae, Michael M; Adjei, George O; Goka, Bamenla; Kurtzhals, Jørgen Al; Puijalon, Odile; Hviid, Lars; Akanmori, Bartholomew D; Behr, Charlotte.

I: Malaria Journal, Bind 11, Nr. 1, 2012, s. 253.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Boeuf, PS, Loizon, S, Awandare, GA, Tetteh, JK, Addae, MM, Adjei, GO, Goka, B, Kurtzhals, JA, Puijalon, O, Hviid, L, Akanmori, BD & Behr, C 2012, 'Insights into deregulated TNF and IL-10 production in malaria: implications for understanding severe malarial anaemia', Malaria Journal, bind 11, nr. 1, s. 253. https://doi.org/10.1186/1475-2875-11-253

APA

Boeuf, P. S., Loizon, S., Awandare, G. A., Tetteh, J. K., Addae, M. M., Adjei, G. O., Goka, B., Kurtzhals, J. A., Puijalon, O., Hviid, L., Akanmori, B. D., & Behr, C. (2012). Insights into deregulated TNF and IL-10 production in malaria: implications for understanding severe malarial anaemia. Malaria Journal, 11(1), 253. https://doi.org/10.1186/1475-2875-11-253

Vancouver

Boeuf PS, Loizon S, Awandare GA, Tetteh JK, Addae MM, Adjei GO o.a. Insights into deregulated TNF and IL-10 production in malaria: implications for understanding severe malarial anaemia. Malaria Journal. 2012;11(1):253. https://doi.org/10.1186/1475-2875-11-253

Author

Boeuf, Philippe S ; Loizon, Séverine ; Awandare, Gordon A ; Tetteh, John Ka ; Addae, Michael M ; Adjei, George O ; Goka, Bamenla ; Kurtzhals, Jørgen Al ; Puijalon, Odile ; Hviid, Lars ; Akanmori, Bartholomew D ; Behr, Charlotte. / Insights into deregulated TNF and IL-10 production in malaria : implications for understanding severe malarial anaemia. I: Malaria Journal. 2012 ; Bind 11, Nr. 1. s. 253.

Bibtex

@article{eb483eca4e574342b66ba183459eb5d9,
title = "Insights into deregulated TNF and IL-10 production in malaria: implications for understanding severe malarial anaemia",
abstract = "ABSTRACT: BACKGROUND: Severe malarial anaemia (SMA) is a major life-threatening complication of paediatric malaria. Protracted production of pro-inflammatory cytokines promoting erythrophagocytosis and depressing erythropoiesis is thought to play an important role in SMA, which is characterized by a high TNF/IL-10 ratio. Whether this TNF/IL-10 imbalance results from an intrinsic incapacity of SMA patients to produce IL-10 or from an IL-10 unresponsiveness to infection is unknown. Monocytes and T cells are recognized as the main sources of TNF and IL-10 in vivo, but little is known about the activation status of those cells in SMA patients. METHODS: The IL-10 and TNF production capacity and the activation phenotype of monocytes and T cells were compared in samples collected from 332 Ghanaian children with non-overlapping SMA (n = 108), cerebral malaria (CM) (n = 144) or uncomplicated malaria (UM) (n = 80) syndromes. Activation status of monocytes and T cells was ascertained by measuring HLADR + and/or CD69+ surface expression by flow cytometry. The TNF and IL-10 production was assessed in a whole-blood assay after or not stimulation with lipopolysaccharide (LPS) or phytohaemaglutinin (PHA) used as surrogate of unspecific monocyte and T cell stimulant. The number of circulating pigmented monocytes was also determined. RESULTS: Monocytes and T cells from SMA and CM patients showed similar activation profiles with a comparable decreased HLA-DR expression on monocytes and increased frequency of CD69+ and HLA-DR + T cells. In contrast, the acute-phase IL-10 production was markedly decreased in SMA compared to CM (P = .003) and UM (P = .004). Although in SMA the IL- 10 response to LPS-stimulation was larger in amplitude than in CM (P = .0082), the absolute levels of IL-10 reached were lower (P = .013). Both the amplitude and levels of TNF produced in response to LPS-stimulation were larger in SMA than CM (P = .019). In response to PHA-stimulation, absolute levels of IL-10 produced in SMA were lower than in CM (P = .005) contrasting with TNF levels, which were higher (P = .01). CONCLUSIONS: These data reveal that SMA patients have the potential to mount efficient IL-10 responses and that the TNF/IL-10 imbalance may reflect a specific monocyte and T cell programming/polarization pattern in response to infection.",
author = "Boeuf, {Philippe S} and S{\'e}verine Loizon and Awandare, {Gordon A} and Tetteh, {John Ka} and Addae, {Michael M} and Adjei, {George O} and Bamenla Goka and Kurtzhals, {J{\o}rgen Al} and Odile Puijalon and Lars Hviid and Akanmori, {Bartholomew D} and Charlotte Behr",
year = "2012",
doi = "10.1186/1475-2875-11-253",
language = "English",
volume = "11",
pages = "253",
journal = "Malaria Journal",
issn = "1475-2875",
publisher = "BioMed Central",
number = "1",

}

RIS

TY - JOUR

T1 - Insights into deregulated TNF and IL-10 production in malaria

T2 - implications for understanding severe malarial anaemia

AU - Boeuf, Philippe S

AU - Loizon, Séverine

AU - Awandare, Gordon A

AU - Tetteh, John Ka

AU - Addae, Michael M

AU - Adjei, George O

AU - Goka, Bamenla

AU - Kurtzhals, Jørgen Al

AU - Puijalon, Odile

AU - Hviid, Lars

AU - Akanmori, Bartholomew D

AU - Behr, Charlotte

PY - 2012

Y1 - 2012

N2 - ABSTRACT: BACKGROUND: Severe malarial anaemia (SMA) is a major life-threatening complication of paediatric malaria. Protracted production of pro-inflammatory cytokines promoting erythrophagocytosis and depressing erythropoiesis is thought to play an important role in SMA, which is characterized by a high TNF/IL-10 ratio. Whether this TNF/IL-10 imbalance results from an intrinsic incapacity of SMA patients to produce IL-10 or from an IL-10 unresponsiveness to infection is unknown. Monocytes and T cells are recognized as the main sources of TNF and IL-10 in vivo, but little is known about the activation status of those cells in SMA patients. METHODS: The IL-10 and TNF production capacity and the activation phenotype of monocytes and T cells were compared in samples collected from 332 Ghanaian children with non-overlapping SMA (n = 108), cerebral malaria (CM) (n = 144) or uncomplicated malaria (UM) (n = 80) syndromes. Activation status of monocytes and T cells was ascertained by measuring HLADR + and/or CD69+ surface expression by flow cytometry. The TNF and IL-10 production was assessed in a whole-blood assay after or not stimulation with lipopolysaccharide (LPS) or phytohaemaglutinin (PHA) used as surrogate of unspecific monocyte and T cell stimulant. The number of circulating pigmented monocytes was also determined. RESULTS: Monocytes and T cells from SMA and CM patients showed similar activation profiles with a comparable decreased HLA-DR expression on monocytes and increased frequency of CD69+ and HLA-DR + T cells. In contrast, the acute-phase IL-10 production was markedly decreased in SMA compared to CM (P = .003) and UM (P = .004). Although in SMA the IL- 10 response to LPS-stimulation was larger in amplitude than in CM (P = .0082), the absolute levels of IL-10 reached were lower (P = .013). Both the amplitude and levels of TNF produced in response to LPS-stimulation were larger in SMA than CM (P = .019). In response to PHA-stimulation, absolute levels of IL-10 produced in SMA were lower than in CM (P = .005) contrasting with TNF levels, which were higher (P = .01). CONCLUSIONS: These data reveal that SMA patients have the potential to mount efficient IL-10 responses and that the TNF/IL-10 imbalance may reflect a specific monocyte and T cell programming/polarization pattern in response to infection.

AB - ABSTRACT: BACKGROUND: Severe malarial anaemia (SMA) is a major life-threatening complication of paediatric malaria. Protracted production of pro-inflammatory cytokines promoting erythrophagocytosis and depressing erythropoiesis is thought to play an important role in SMA, which is characterized by a high TNF/IL-10 ratio. Whether this TNF/IL-10 imbalance results from an intrinsic incapacity of SMA patients to produce IL-10 or from an IL-10 unresponsiveness to infection is unknown. Monocytes and T cells are recognized as the main sources of TNF and IL-10 in vivo, but little is known about the activation status of those cells in SMA patients. METHODS: The IL-10 and TNF production capacity and the activation phenotype of monocytes and T cells were compared in samples collected from 332 Ghanaian children with non-overlapping SMA (n = 108), cerebral malaria (CM) (n = 144) or uncomplicated malaria (UM) (n = 80) syndromes. Activation status of monocytes and T cells was ascertained by measuring HLADR + and/or CD69+ surface expression by flow cytometry. The TNF and IL-10 production was assessed in a whole-blood assay after or not stimulation with lipopolysaccharide (LPS) or phytohaemaglutinin (PHA) used as surrogate of unspecific monocyte and T cell stimulant. The number of circulating pigmented monocytes was also determined. RESULTS: Monocytes and T cells from SMA and CM patients showed similar activation profiles with a comparable decreased HLA-DR expression on monocytes and increased frequency of CD69+ and HLA-DR + T cells. In contrast, the acute-phase IL-10 production was markedly decreased in SMA compared to CM (P = .003) and UM (P = .004). Although in SMA the IL- 10 response to LPS-stimulation was larger in amplitude than in CM (P = .0082), the absolute levels of IL-10 reached were lower (P = .013). Both the amplitude and levels of TNF produced in response to LPS-stimulation were larger in SMA than CM (P = .019). In response to PHA-stimulation, absolute levels of IL-10 produced in SMA were lower than in CM (P = .005) contrasting with TNF levels, which were higher (P = .01). CONCLUSIONS: These data reveal that SMA patients have the potential to mount efficient IL-10 responses and that the TNF/IL-10 imbalance may reflect a specific monocyte and T cell programming/polarization pattern in response to infection.

U2 - 10.1186/1475-2875-11-253

DO - 10.1186/1475-2875-11-253

M3 - Journal article

C2 - 22853732

VL - 11

SP - 253

JO - Malaria Journal

JF - Malaria Journal

SN - 1475-2875

IS - 1

ER -

ID: 38564764